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Abstract 
We have determined the nucleotide sequences of the coding region in the last 
two coding exom of ABO genes (which occupy 91% of the soluble form of A’ 
transferase) from 7 individuals with weak subgroup phenotypes. Four of thc 
individuals had an A, phenotype and 3 individuals had a B3 phenotype. We 
determined the nucleotide sequences based on PCR followed by subcloning 
and DNA sequencing of the amplified fragments. Two cases of the A’ allele 
and lcase of the B’ allele were found to contain a single-base substitution 
which resulted in an amino acid substitution. However, no other cases of A3 
and B3 alleles were found to contain differences in this region. This finding 
demonstrates for the first time heterogeneity among these weak subgroups at 
the nucleotide level. ....................* 
Introduction 
Since the discovcry of the histo-blood group ABO sys- 
tem by Landsteiner in 1900 [l], almost a century passed 
until we were successfully able to elucidate the molecular 
genetic basis of the three major alleles (A’, B, and 0) at 
the blood group ABO gene locus by cloning A’ transferase 
cDNA [2], and by cloning B and 0 alleles [3] followed by 
nuclcotide sequencing. 0 alleles are characterized by the 
presence of a single-base delction close to the N-terminal 
of the coding sequence, which shifts the reading frame of 
codons and results in the translation of an entirely differ- 
ent protein thereafter without any activity of A or B trans- 
fcrases. A’- and B-allelic cDNAs are identical cxccpt for 
seven nucleotide substitutions resulting in four amino acid 
substitutions between A’ and B transferases. 
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We have subsequently extended our study to sub- 
groups. Subgroups of A, Al and A2 were first identified by 
von Dungern in 1911 when he found two kinds o f  group A 
crythrocytes. Sera from blood group B individuals con- 
tain two types of antibodies against A antigens: anti-A 
and anti-A,. Group A erythrocytes, which react with both 
anti-A and anti-Al were namcd A,, and those which react 
only with anti-A, were named A,. Dolichos biflorus lectin 
has been used as an anti-Al reagent. Wc analyzed A’/A? 
differences at the nucleotide level and found a single-base 
substitution and a single-base deletion in the coding se- 
quence of the last coding exon of A2 alleles [4]. These two 
differences wcre found present in all the A’ alleles tcstcd 
(8 specimens). The single-base delction is located close to 
the carboxyl terminal of the transferase in the coding se- 
quence. As a result of frame shifting, A* transferase has an 
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additional domain composed of 21 amino acids. We con- 
structed an A' transferase expression construct and per- 
formed DNA transfection experiments. We found this 
single-nucleotide deletion to be responsible for the weak 
A transferase activity in A' transferase. 
In addition to A>, there are other rare subgroups with 
weaker serological reactivity compared to A, .  These can 
be serologically differentiated and include A3, A,, Acrid, 
and Ael. Similarly, B phenotypes with weaker than normal 
B activity are designated as B3, B,, B,, Be,. These weak 
subgroups are of great importance because they allow us 
to chariicterize their specific glycosyltransferase by study- 
ing the mutations in these alleles. A3 erythrocytes are 
characterized by a mixed-field pattern of agglutination 
with anti-A or anti-A,B reagents. B3, the counterpart of 
A3 in B, is similarly characterized by a mixed-field aggluti- 
nation of erythrocytes with anti-B or  anti-A,B reagents. 
Because roughly two thirds of the red cells are agglutinat- 
ed, A3 and B3 are also called Ah,) and B6(), respectively [ S ] .  
Here we report the identification of mutations in the 
nucleot ide sequences of the coding region in some cases of 
A3 and B-' alleles. 
Materials and Methods 
Blood C;roiiprng 
We h,ive analyzed a total of 7 cases of weak subgroups; one A,B3, 
two A?, twoA,B, twoBi. Bloodgroups were determined using immu- 
nological methods. One case (A,B1) was confirmed to posses a B' 
allele through the grouping of its family members. 
PCR .4 I I iplificu tion 
Genomic DNA was prepared from blood specimens by Proteinase 
K-SDS method [6]. Reagents for PCR [7] reaction were purchased 
from Perkin-Elmer Cetus. The pairs of synthetic oligodeoxynucleo- 
tides used for PCR are as follows: 
fy-121, CGGAATTCCATGTGACCGCACGCCT and 
fy-122, CGGAATTCTCTACCCTCGGCCAf'C; 
fy-101, CG(jAAT"TCCCGTCCGCCTGCC~GCAG and 
fy-113, C'(j(;AATTCACCTCTTGCACCGACCC; 
and fy-1 I 2.  ('GGAATTCCGTTCTGCTAA A ACCAAG 
and fy-114. C'CTGGTGTGCGTGGAC, or 
fy-127, C'G GAATTCCTGGTGTGCGTGGAC. 
The oligodeoxynucleotide fy-127 is essentially identical to fy-114 ex- 
cept for the additional EcoRI site at the 5' end. All the EcoRI sites are 
artifical i n  order to facilitate the subsequent subcloning. The reaction 
mixture was denatured for 5 min at 95°C followed by 45 cycles of 30 s 
at94"C, 30sat55"C,and30 sat 72"CinaDNAthermalcycler. DNA 
was extracted with pheno1:chloroform:isoamylalcohol = 25:24:1 and 
precipitat ecl with ethanol. 
Subcloning nnd DNA Sequencing 
After resuspension, DNA was digested with EcoRI, electropho- 
resed on :in iigarose gel. and the major fragments with expected size 
were excised and DNA was extracted with GeneClean kit (Bio 101). 
Gel-purified DNA was then ligated with either EcoRI-digested, de- 
phosphorylated sequencing vector pT7T3U18 (Pharmacia-LKB) 
(fy-121-fy-122, fy-101-fy-113, and fy-112-fy-127), or the same vector 
double digested with EcoRI and SmaI (fy-112-fy-114). Ligated DNA 
was used to transform XLl-blue strain of Escherichia coli. Plasmid 
DNA was prepared from a multiple number of transformants, ana- 
lyzed for theinsert, denatured. and usedfornucleotide sequencing by 
the Sanger method [8] with Sequenase (United States Biochemical). 
Results 
Figure 1 shows the schematic comparison of the nucle- 
otide and the deduced amino acid sequences of each allele 
from 7 individuals 5howing phenotypes of weak sub- 
groups, A3 or Bi, with those of A', 0, and B alleles. 
Two pairs of oligo primers, fy-101 & fy-113 and fy-112 & 
fy-114/fy-127, were used to amplify the coding sequence in 
the last coding exon. The corresponding sequence for 
primer fy-101 resides in the intron preceding this last cod- 
ing exon (the last base of fy-101 is located just adjacent to 
the splicing acceptor site), and that of fy-112 resides in the 
3' untranslated region (the last base of fy-112 is located 53 
bases away from the termination codon on the 3' 4ide). 
Primers fy-113 and fy-1141fy-127 are homologous to the 
sequences in the last exon except for the artifical EcoRI 
sequences of fy-113 and fy-127, and the amplified frag- 
ments from these pairs of oligos overlap one another. The 
third pair of oligos was used to amplify the preceding 
exon. The corresponding sequences for fy-121 and fy-122 
reside in the introns preceding and following this exon, 
respectively. The last base of fy-121 is located 16hases 
away from the 5' side of the splicing acceptor site and that 
of fy-122 is located 11 bases away from the 3' side of the 
splicing donor site. Nucleotide sequencing of multiple 
(more than 10) clones of transformants, transformed with 
each PCR-amplified fragment, was performed to discrim- 
inate between the two alleles on the two homologous 
chromosomes as well as the occasional errors introduced 
by Toq DNA polymerase. 
We were able to discriminate the two alleles on homo- 
logous chromosome pairs in 5 out of the7 samples tested, 
based on differences in the nucleotide sequences. How- 
ever, even with our extensive sequencing we were unable 
to discriminate the two homologously paired alleles in  the 
remaining 2cases (both with a phenotype of A?) in the 
coding sequence of the last coding exon. More than twen- 
ty transformant clones showed an identical sequence sug- 
gesting that these A' alleles are identical to A' alleles in 
this region. Figure 1 shows this conclusion. There appears 
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Fig. 1. Schematic comparison of the nu- 
cleotide and thc dcduccd amino acid se- 
qucncesofeach allele from individuals show- 
ing weak subgroup phenotypes, A3 or B3, 
with those of A', 0, and B alleles. The A 
residue and the methionine residue of the 
initiation codoii of A' transferase are num- 
bered I (because of the deletion of the three 
nucleotides in FY-59-5 clone. the numbering 
is different from that of FY-59-5 presented in 
reference [ 2 ] .  Because only the last two cod- 
ing exons were analyzed forA3 and B3 alleles, 
oiily the sequences in this region are com- 
pared and thc differcnccs arc indicatcd. For 
each specimen, the two alleles which made 
up homologous chromosome pairs were dis- 
criminated from one another by differences 
in the nucleotide sequences. For the two A'O 
individuals, we were unablc to discriminate 
between the two honiologously paircd allelcs 
in the last coding exon. We assume these A' 
alleles are identical to A' alleles in the last 
coding exon because no differences were 
found among more than twenty transformant 
cloncs. Thc figure shows this conclusion. The 
hatched rectangle in 0 alleles indicates the 
entirely different deduced amino acid se- 
quence due to frame shifting caused by the 
single-base deletion. The arrow shows the 
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to be at least two kinds of A' and B' alleles. The A' alleles 
from two A3B individuals have a single-base substitution 
at nt. 871 (G + A) resulting in an amino acid substitution 
at aa.  291 (aspartic acid + asparagine) which discrimi- 
nates these A3 alleles from A' alleles. The B3 allele from 
one AIBl individual has a single-base substitution at nt. 
1054 (C+ T) resulting in an amino acid substitution at aa. 
352 (arginine + tryptophan), which discriminates this B3 
allele from B alleles. 
Discussion 
Heterogeneity among the single subgroups has been 
reported for A and B variants based on the analysis of 
transferase activity in the serum of these individuals. Car- 
tron et al. [9] reported three types of A, phenotypes. One 
group consisted of A3 phenotypes with a low lcvcl of A 
transferase activity in the serum, and the optimal pH of 
the transferase was approximately 7 (in 7 out of 11 cases). 
The second group consisted of A3 phenotypes with no 
activity of A transferase (3 out of the 11). A high A trans- 
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ferase 'ictivity optimum at pH 6 was detected in the last of 
eleven A ,  samples. Nakamura et al. [lo] reported an ac- 
tive A trnnsferase which has characteristics (the level of 
activit), pH optimum, K,, V,,,,, and heat stability) identi- 
cal to thme of A'  transferase in the serum of A 3  pheno- 
types. These authors postulated that the weak A expres- 
sion is duc to the suppression of A transferase production 
only in hemopoietic tissues. B transferase activity in the 
serum o f  individuals with B7 phenotype has been reported 
to vary from 10 to 100% of control level [ll]. Due to the 
restricted availability of blood specimens, we have not yet 
performed any enzymological analyses. 
Bec'me of our incomplete knowledge of the exon-in- 
tron boundaries of ABO genes and the restricted avail- 
ability ot  \ample specimens, we focused our efforts on the 
identification of differences in the coding sequence of the 
last two coding exons. Although there may be more differ- 
ences wmewhere outside of these exons (including differ- 
ences in  the splicing pattern), 91% of the soluble form of 
A' tran\fcrase is contained in these two exons and exten- 
sive nucleotide and deduced amino acid sequence homol- 
ogies wt th  a1 +3 galactosyltransferase gene are observed 
only in this region [12] suggesting the importance of the 
last two coding exons for transferase activity. 
We liave identified nucleotide substitutions, which re- 
sult in cimino acid substitutions, in the last coding exon of 
some ot A '  and B' alleles. The fact that these differences 
were n o t  found common to all the samples with the same 
weak subgroups indicates heterogeneity in each group. 
There is a possibility that only those cases which identify 
differences in the nucleotide sequence are genuine weak 
subgroups and the rest are caused by changes in physical 
conditions due to illness, diet etc. A decrease of A and B 
antigens in patients with leukemia has been well docu- 
mented [13]. 
The computational calculation using the IBI Pustell 
Sequence Analysis Program indicates the decrease of flex- 
ibility around these amino acid substitutions (aspartic acid 
+ asparagine at aa. 291 in two A3 alleles and arginine + 
tryptophan at aa. 352 in a B' allele) as well as the changes 
in the isoelectric point. The amino acid substitution at aa. 
291 has also been calculated to  disrupt the a-helix struc- 
ture around this amino acid. These changes may be re- 
sponsible for the weak activities of these alleles. Future 
studies by molecular biological approaches (construction 
of expression constructs with these nucleotide and result- 
ing amino acid substitutions and expression study by 
DNA transfection) may clarify whether these changes are 
sufficient for explaining these weak phenotypes. When 
the complete exon-intron boundaries and promoter se- 
quences are defined for ABO genes, mutations in other 
A3 and B3 alleles will be clearly identified. 
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